CATHETER SITE DISCOLOURATION

This adverse event was reported 122 times

These drugs are most commonly taken by patients reporting CATHETER SITE DISCOLOURATION:

# Drug Count
0 TREPROSTINIL 34
1 MACITENTAN 28
2 SILDENAFIL CITRATE 28
3 EPOPROSTENOL 26
4 AMBRISENTAN 20
5 FOSCARBIDOPA/FOSLEVODOPA 19
6 TADALAFIL 18
7 APIXABAN 15
8 SILDENAFIL 15
9 WARFARIN 11
See all common drugs associated with CATHETER SITE DISCOLOURATION

CATHETER SITE DISCOLOURATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ALUMINUM CHLORIDE 1 0.0066
1 GOLODIRSEN 2 0.0041
2 FOSCARBIDOPA/FOSLEVODOPA 19 0.0022
3 EPOPROSTENOL 26 0.0020
4 IDURSULFASE 6 0.0015
5 TEPLIZUMAB-MZWV 1 0.0014
6 SOTATERCEPT-CSRK 5 0.0008
7 MIDODRINE HYDROCHLORIDE 3 0.0007
8 CARBIDOPA TABLETS 2 0.0007
9 ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL 1 0.0006
See all drugs enriched for association with CATHETER SITE DISCOLOURATION